Executive Vice President and Head of Sanofi Genzym
Pharma
Sanofi Genzyme
Ireland
Bill Sibold is Executive Vice President and Head of Sanofi Genzyme, the specialty care global business unit of Sanofi. In this role, he is a member of the Sanofi Executive Committee. Previously, Bill was the Global Head of Sanofi Genzyme’s Multiple Sclerosis, Oncology and Immunology franchises, and led the preparation for the launches of two important new immunology treatments.
he leads the business’s efforts to maintain its leadership in rare diseases while continuing to grow in multiple sclerosis, oncology and immunology.